IART Stock Cash Flow Statements

Integra LifeSciences Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Integra LifeSciences Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2001-03-31

operating activities:
net income	-484,073,000	-25,293,000	19,435,000	-10,696,000	-12,402,000	-3,281,000	19,834,000	19,497,000	4,184,000	24,226,000	52,946,000	49,915,000	44,788,000	32,901,000	45,384,000	43,229,000	35,068,000	45,394,000	92,744,000	32,337,000	-369,000	9,180,000	15,319,000	-27,610,000	29,736,000	32,756,000	25,138,000	13,295,000	11,376,000	10,992,000		3,158,000	10,836,000	6,394,000		20,143,000	14,525,000	11,648,000		-31,881,000	4,998,000	8,384,000		9,807,000	4,825,000	2,206,000		-28,550,000	3,440,000	-4,050,000		13,211,000	8,514,000	6,693,000	4,560,000	11,243,000	699,000	11,487,000	18,807,000	16,483,000	15,157,000	15,222,000	15,731,000	14,432,000	11,225,000	9,567,000	24,845,000	-15,291,000	13,814,000	11,565,000	5,382,000	9,673,000	9,342,000	9,074,000	1,996,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	37,692,000	37,188,000	37,589,000	35,961,000	36,777,000	30,566,000	30,985,000	30,558,000	30,826,000	31,143,000	29,496,000	29,467,000	29,612,000	29,724,000	30,746,000	30,122,000	29,754,000	29,214,000	26,178,000	31,027,000	29,675,000	29,151,000	27,878,000	27,599,000	26,892,000	27,093,000	27,677,000	29,051,000	26,906,000	27,096,000		20,969,000	21,595,000	19,717,000		18,086,000	18,014,000	18,253,000		9,437,000	15,745,000	15,414,000		15,941,000	15,203,000	13,961,000		11,670,000	12,636,000	11,389,000		13,314,000	13,232,000	12,576,000	12,869,000	12,852,000	14,493,000	9,958,000	10,504,000	9,714,000	9,523,000	9,431,000	12,572,000	9,973,000	8,467,000	8,676,000	8,773,000	7,900,000	6,971,000	7,073,000	6,418,000	6,013,000	7,532,000	5,664,000	1,431,000
non-cash impairment charges			36,000	29,000	5,080,000	7,064,000									0	0	0	2,754,000					0	0			0														0	409,000		0	0	600,000
deferred income tax benefit	-44,831,000	-1,832,000	-6,988,000												10,743,000	-8,591,000	-3,673,000	-1,234,000																														-6,838,000	655,000	-1,055,000						759,000	-3,228,000	-1,981,000		-1,289,000	-6,000	-369,000					-17,852,000	-8,716,000			-7,478,000	-2,242,000
share-based compensation	5,295,000	1,870,000	7,152,000	4,382,000	7,244,000	5,599,000	5,793,000	5,459,000	5,271,000	3,620,000	5,731,000	8,967,000	6,736,000	6,291,000	6,432,000	7,745,000	15,699,000	6,334,000	5,257,000	5,411,000	5,172,000	3,750,000	5,511,000	5,885,000	5,776,000	4,083,000	4,993,000	5,572,000	5,483,000	4,731,000		5,309,000	5,687,000	5,363,000		4,876,000	4,651,000	3,246,000		6,172,000	3,239,000	2,377,000		3,386,000	5,831,000	2,471,000		2,830,000	2,692,000	2,072,000		2,277,000	2,285,000	2,070,000	7,908,000	3,034,000	11,829,000	4,034,000	5,756,000	3,933,000	3,677,000	3,843,000	4,059,000	3,790,000	3,971,000	3,760,000	3,910,000	21,647,000	3,600,000	3,478,000	4,432,000	3,780,000	3,826,000	3,356,000
amortization of debt issuance costs and expenses associated with debt refinancing	1,890,000	1,385,000	1,400,000	1,335,000	1,460,000	1,398,000	1,433,000	1,417,000	1,424,000	1,890,000	1,703,000	1,750,000	1,668,000	1,724,000	1,722,000	1,739,000	1,848,000	1,721,000	1,577,000	4,948,000	1,305,000	4,246,000
non-cash lease expense	-345,000	-254,000	964,000	-825,000	547,000	149,000	69,000	369,000	491,000	1,260,000	-224,000	1,647,000	1,410,000	-17,000	735,000	571,000	1,006,000	1,522,000	783,000	412,000
loss on disposal of property and equipment	-1,000	495,000										182,000	20,000	712,000		1,943,000	88,000	-2,000		42,000	143,000	374,000	977,000	233,000	244,000	367,000	416,000	842,000	-19,000	146,000		-9,000	104,000	348,000		-138,000				86,000				127,000				-15,000	-34,000	1,865,000		376,000								-284,000	293,000	154,000
change in fair value of contingent consideration and others	-41,000	-162,000	-5,472,000	-2,123,000	1,348,000	456,000	4,610,000	2,197,000	1,382,000	4,699,000	-823,000	-13,682,000	-5,034,000	-765,000	-1,618,000	-159,000	-666,000	281,000	996,000	663,000	343,000	-1,051,000
changes in assets and liabilities:
accounts receivable	-27,991,000	21,451,000	-31,463,000	28,750,000	-6,716,000	16,827,000	-457,000	224,000	-5,215,000	10,041,000	-10,035,000	-14,238,000	-6,516,000	-3,116,000	-10,172,000	6,635,000	-5,954,000	16,756,000	-5,758,000	-37,430,000	66,992,000	28,301,000	8,091,000	12,837,000	-16,651,000	-13,705,000	-18,201,000	9,600,000	9,980,000	-18,400,000		1,442,000	-10,714,000	-589,000		5,425,000	4,915,000	-18,440,000		-4,726,000	-6,580,000	2,100,000		-3,953,000	-5,565,000	5,671,000		2,185,000	-2,854,000	2,109,000		-3,585,000	-2,548,000	4,800,000	-1,101,000	-76,000	-1,797,000	1,096,000	474,000	-6,944,000	-591,000	3,278,000	-1,856,000	1,758,000	765,000	9,141,000	-2,097,000	649,000	-646,000	-2,616,000	-3,015,000	4,243,000	-3,529,000	-540,000	393,000
inventories	-6,378,000	-13,696,000	-570,000	-10,301,000	1,743,000	-19,021,000	-16,423,000	-15,795,000	-2,132,000	-25,423,000	-4,681,000	-6,867,000	-6,015,000	-11,561,000	8,972,000	-6,491,000	5,225,000	-2,332,000	-2,817,000	1,510,000	-20,805,000	-26,236,000	-12,755,000	-8,995,000	-9,510,000	-12,048,000	11,741,000	155,000	-4,893,000	1,297,000		4,602,000	-257,000	-5,207,000		-1,699,000	742,000	-8,104,000		1,870,000	-7,086,000	-2,789,000		-9,281,000	-8,851,000	-8,516,000		-10,889,000	-15,081,000	-8,885,000		3,235,000	-1,302,000	-853,000	8,490,000	2,762,000	-4,780,000	-4,770,000	1,029,000	-649,000	-5,555,000	-2,199,000	2,650,000	518,000	3,544,000	2,693,000	11,502,000	4,758,000	-5,616,000	179,000	-1,270,000	-7,489,000	-9,662,000	-170,000	-2,212,000
prepaid expenses and other current assets	-3,665,000	-17,551,000	26,214,000	-17,628,000	-14,097,000	-2,676,000	24,352,000	-11,188,000	-8,348,000	-2,164,000	6,983,000	5,749,000	926,000	-5,046,000	-9,447,000	-3,635,000	-4,487,000	-3,574,000	2,497,000	-3,056,000	-2,492,000	4,683,000	21,233,000	6,644,000	-1,857,000	-12,949,000	501,000	5,391,000	-14,122,000	12,163,000		-5,455,000	-7,248,000	-1,988,000		-3,311,000	2,346,000	2,016,000		14,737,000	-13,317,000	6,003,000		9,460,000	-1,250,000	-1,582,000		342,000	-3,496,000	2,872,000		484,000	6,045,000	1,619,000	151,000	-1,738,000	-1,679,000	2,871,000	-10,556,000	7,981,000	-3,056,000	-821,000	-9,602,000	-3,199,000	1,240,000	7,247,000	34,791,000	-17,430,000	-11,488,000	-1,899,000	-5,110,000	3,800,000	-679,000	2,605,000	-99,000
other non-current assets	824,000	1,510,000	-1,097,000	-11,266,000	9,182,000	339,000	239,000	-590,000	-2,175,000	-6,009,000	-11,757,000	2,837,000	4,455,000	2,283,000	1,975,000	1,833,000	-6,352,000	10,419,000	2,867,000	4,719,000	3,149,000	3,000,000	6,506,000	3,804,000	3,474,000	-628,000	2,449,000	-961,000	-775,000	339,000		-166,000	-1,490,000	-321,000		19,000	30,000	-601,000		3,030,000	-76,000	-1,730,000		1,409,000	-1,719,000	-127,000		-147,000	-253,000	-115,000		-1,000	-724,000	-152,000	436,000	64,000	-210,000	85,000	30,000	-411,000	6,000	196,000	-2,327,000	-2,686,000	4,514,000	910,000	-408,000	1,491,000	-650,000	-535,000	-340,000	-3,494,000	-2,211,000	6,409,000
accounts payable, accrued expenses and other current liabilities	15,922,000	-18,000,000	-5,360,000	6,826,000	15,070,000	-19,210,000	1,912,000	-6,242,000	-10,915,000	-4,984,000	18,146,000	13,753,000	-4,802,000	-9,754,000	-984,000	6,581,000	12,828,000	14,449,000	9,666,000	21,493,000	-48,436,000	-40,235,000	14,300,000	-16,044,000	11,023,000	5,387,000	-5,830,000	12,823,000	-6,379,000	2,974,000		3,734,000	11,349,000	8,938,000		3,594,000	-5,769,000	8,006,000		-10,265,000	21,498,000	-1,885,000		3,946,000	9,286,000	-4,438,000		11,292,000	3,408,000	-515,000		-850,000	5,257,000	2,121,000	-7,657,000	-8,609,000	7,221,000	-2,797,000	-5,613,000	6,308,000	2,845,000	3,196,000	9,718,000	3,763,000	-3,511,000	-5,420,000	-18,346,000	5,140,000	-1,881,000	-2,171,000
contract liabilities	2,100,000	244,000	1,718,000	-347,000	3,667,000	-1,498,000	-13,000	-583,000			1,750,000	1,750,000						-83,000	511,000	89,000	-975,000	338,000	788,000	576,000
other non-current liabilities	1,156,000	1,388,000	-1,429,000	7,359,000	-7,911,000	1,888,000	483,000	110,000	13,070,000	-14,073,000	9,850,000	-6,170,000	-5,542,000	-2,576,000	-15,619,000	1,027,000	10,144,000	-9,662,000	2,528,000	-2,006,000	-1,127,000	-2,284,000	-2,656,000	-489,000	-3,522,000	4,608,000	-155,000	-4,246,000	4,861,000	-69,000		9,227,000	-1,100,000	-5,685,000		829,000	-690,000	-386,000		-687,000	-932,000	1,547,000		-2,358,000	-643,000	-2,309,000		-726,000	-174,000	-364,000		-1,695,000	33,000	399,000		-1,001,000	-79,000	-198,000		-7,312,000	2,280,000	-2,836,000		184,000	-280,000	402,000				1,051,000				-4,477,000
net cash from operating activities	8,919,000	-11,257,000	50,740,000	22,485,000	40,401,000	15,756,000	58,750,000	26,770,000	28,279,000	26,156,000	85,334,000	68,313,000	66,478,000	44,344,000	69,277,000	82,779,000	91,290,000	69,081,000	80,262,000	69,639,000	33,117,000	20,814,000	89,184,000	64,241,000	48,524,000	29,484,000	42,688,000	79,251,000	36,213,000	41,531,000	11,549,000	45,242,000	28,871,000	28,882,000	6,529,000	46,767,000	43,938,000	19,171,000	37,601,000	19,349,000	18,123,000	31,619,000	20,757,000	31,075,000	16,377,000	11,254,000	11,696,000	30,808,000	2,918,000	7,846,000	-3,788,000	27,909,000	2,276,000	32,318,000	34,695,000	23,795,000	24,583,000	21,255,000	28,430,000	29,646,000	19,358,000	28,137,000	47,044,000	28,366,000	30,638,000	37,187,000	27,091,000	27,128,000	-1,975,000	20,346,000	14,593,000	10,672,000	6,479,000	15,282,000	4,550,000
capex	-20,146,000	-28,920,000	-29,600,000	-29,646,000	-29,707,000	-15,465,000	-24,535,000	-13,078,000	-15,548,000	-13,704,000	-14,456,000	-9,155,000	-9,407,000	-9,325,000	-27,427,000	-7,286,000	-6,634,000	-6,675,000	-8,427,000	-6,727,000	-7,217,000	-16,519,000	-22,194,000	-13,593,000	-17,664,000	-16,086,000	-25,685,000	-16,669,000	-20,000,000	-15,387,000	0	-7,796,000	-12,819,000	-9,191,000	0	-6,974,000	-8,267,000	-10,895,000	0	1,699,000	-13,112,000	-8,901,000	0	-8,775,000	-9,356,000	-11,335,000	0	-13,247,000	-13,622,000	-10,853,000	0	-19,717,000	-14,230,000	-10,412,000	-13,044,000	-12,243,000	-7,216,000	-5,922,000	-18,241,000	-7,206,000	-5,747,000	-5,944,000	-11,287,000	-5,682,000	-5,223,000	-3,046,000	-4,108,000	-3,190,000	-3,259,000	-2,844,000	-5,327,000	-6,179,000	-7,217,000	-3,849,000	-396,000
free cash flows	-11,227,000	-40,177,000	21,140,000	-7,161,000	10,694,000	291,000	34,215,000	13,692,000	12,731,000	12,452,000	70,878,000	59,158,000	57,071,000	35,019,000	41,850,000	75,493,000	84,656,000	62,406,000	71,835,000	62,912,000	25,900,000	4,295,000	66,990,000	50,648,000	30,860,000	13,398,000	17,003,000	62,582,000	16,213,000	26,144,000	11,549,000	37,446,000	16,052,000	19,691,000	6,529,000	39,793,000	35,671,000	8,276,000	37,601,000	21,048,000	5,011,000	22,718,000	20,757,000	22,300,000	7,021,000	-81,000	11,696,000	17,561,000	-10,704,000	-3,007,000	-3,788,000	8,192,000	-11,954,000	21,906,000	21,651,000	11,552,000	17,367,000	15,333,000	10,189,000	22,440,000	13,611,000	22,193,000	35,757,000	22,684,000	25,415,000	34,141,000	22,983,000	23,938,000	-5,234,000	17,502,000	9,266,000	4,493,000	-738,000	11,433,000	4,154,000
investing activities:
purchases of property and equipment	-20,146,000	-28,920,000	-29,600,000	-29,646,000	-29,707,000	-15,465,000	-24,535,000	-13,078,000	-15,548,000	-13,704,000	-14,456,000	-9,155,000	-9,407,000	-9,325,000	-27,427,000	-7,286,000	-6,634,000	-6,675,000	-8,427,000	-6,727,000	-7,217,000	-16,519,000	-22,194,000	-13,593,000	-17,664,000	-16,086,000	-25,685,000	-16,669,000	-20,000,000	-15,387,000		-7,796,000	-12,819,000	-9,191,000		-6,974,000	-8,267,000	-10,895,000		1,699,000	-13,112,000	-8,901,000		-8,775,000	-9,356,000	-11,335,000		-13,247,000	-13,622,000	-10,853,000		-19,717,000	-14,230,000	-10,412,000	-13,044,000	-12,243,000	-7,216,000	-5,922,000	-18,241,000	-7,206,000	-5,747,000	-5,944,000	-11,287,000	-5,682,000	-5,223,000	-3,046,000	-4,108,000	-3,190,000	-3,259,000	-2,844,000	-5,327,000	-6,179,000	-7,217,000	-3,849,000	-396,000
cash paid for business acquisitions, net of cash acquired															0
purchases of short term investments	-1,502,000	-7,000,000	0
net cash from investing activities	-21,648,000	-35,920,000	-4,249,000	-10,396,000	-322,198,000	-53,965,000	-57,229,000	-7,697,000	-15,548,000	-13,704,000	-54,820,000	14,805,000	-4,498,000	-14,067,000	-27,485,000	-8,475,000	-7,917,000	-117,566,000	-35,921,000	-6,718,000	-3,949,000	-21,485,000	-20,609,000	-108,839,000	-17,414,000	-15,806,000	-25,330,000	-16,343,000	1,266,000	-9,298,000	-983,568,000	-7,107,000	-37,517,000	-193,143,000	-21,142,000	-6,707,000	-8,043,000	-6,730,000	-30,758,000	-315,448,000	-13,112,000	-5,632,000	-98,851,000	-8,775,000	-9,356,000	-246,335,000	-10,127,000	-13,394,000	-13,688,000	-13,087,000	-29,773,000	19,855,000	-5,523,000	-63,835,000	-15,575,000	-80,864,000			-19,248,000	-8,956,000	-8,168,000	-5,944,000	-67,284,000	-8,658,000			-13,138,000	-81,001,000				-6,515,000			-3,287,000
financing activities:
proceeds from borrowings of long-term indebtedness	12,900,000	54,400,000	35,400,000	21,800,000	58,800,000	370,500,000	18,200,000	131,700,000	5,000,000	10,200,000	6,500,000	11,250,000	11,750,000	11,250,000	12,050,000	11,250,000	1,600,000	600,000	20,200,000	23,600,000	14,500,000	113,200,000	21,100,000	114,600,000	34,000,000	67,200,000
payments on debt	-15,887,000	-15,244,000	-39,943,000	-41,544,000	-90,544,000	-15,100,000	-24,700,000	-56,800,000	-16,700,000	-12,400,000	-107,800,000	-17,750,000	-11,250,000	-11,750,000	-11,250,000	-12,050,000	-100,000,000	-2,200,000	0	-52,500,000	-44,300,000	-344,200,000	-102,850,000	-38,250,000	-47,600,000	-57,400,000
payment of debt issuance costs							-301,000	0	0	-7,578,000					0	0			0	-4,083,000	0	-20,264,000						-167,000																				-40,000
purchases of treasury stock				0				-125,000,000	0	-150,000,000		0	0	-125,000,000						0	0	-100,000,000																																	-14,452,000	-12,002,000	-52,689,000	-4,320,000	0												-20,465,000	0	-74,994,000	-11,075,000
payments for contingent considerations	-13,851,000	-2,600,000
proceeds from exercised stock options	0	957,000	0	0	0	6,398,000	225,000	655,000	1,111,000	2,326,000	3,873,000	0	353,000	1,239,000	236,000	2,985,000	1,381,000	2,222,000	1,411,000	223,000	1,295,000	2,303,000	0	4,735,000	463,000	1,750,000	153,000	5,512,000	65,000	3,662,000		0	8,607,000	1,167,000		665,000	8,222,000	1,038,000		0	7,114,000	231,000		0	562,000	7,755,000		186,000	0	234,000		446,000			153,000	247,000			10,444,000	1,069,000				2,038,000	569,000	23,000		5,565,000	2,515,000	1,113,000		4,778,000	4,366,000	7,471,000
cash taxes paid in net equity settlement	-225,000	-2,136,000	-136,000	-171,000	-81,000	-3,122,000	-314,000	-214,000	-104,000	-5,231,000	-272,000	-1,142,000	-14,000,000	-9,204,000	-515,000	-442,000	-207,000	-3,637,000	-389,000	-289,000	-49,000	-4,348,000	-242,000	-60,000	-55,000	-6,157,000	-406,000	-175,000	-464,000	-6,776,000		-265,000	-370,000	-6,128,000		-298,000
net cash from financing activities	-21,139,000	35,377,000	-7,150,000	-19,915,000	-93,748,000	358,676,000	-6,890,000	-49,659,000	-10,693,000	-162,683,000	-97,699,000	-7,642,000	-13,147,000	-133,465,000					21,222,000	-33,049,000	-28,553,000	162,005,000			-13,192,000	5,393,000	-84,055,000	-39,839,000	-36,092,000	-20,886,000		286,370,000	33,324,000	185,039,000	13,763,000	-19,797,000	-24,893,000	15,811,000	-17,512,000	245,575,000	44,276,000	-13,826,000	11,740,000	-13,192,000	1,062,000	243,174,000	-488,000	184,000	19,066,000	257,000	3,202,000	460,000	21,033,000	-12,560,000	-27,107,000	36,377,000	95,322,000	-44,455,000	38,674,000	-37,004,000	6,220,000	-9,464,000	-13,109,000	-54,013,000	-76,263,000	-27,957,000	62,539,000	86,268,000	-116,272,000	121,001,000	-17,794,000	4,444,000	125,199,000	-3,364,000	39,000
effect of exchange rate changes on cash and cash equivalents	12,678,000	4,529,000	-8,123,000	7,747,000	-1,125,000	-4,963,000	8,039,000	-4,874,000	-213,000	937,000	11,909,000	-10,691,000	-8,773,000	-3,168,000	904,000	-3,230,000	2,540,000	-9,690,000	8,324,000	5,426,000	2,654,000	-2,533,000	4,347,000	-4,530,000	1,141,000	-884,000	-456,000	-849,000	-7,012,000	3,114,000		2,838,000	5,809,000	1,280,000		532,000	-1,285,000	702,000		-1,201,000	2,138,000	-4,284,000		-6,037,000	39,000	331,000		2,634,000	649,000	-2,263,000		2,024,000	-958,000	1,911,000	-2,196,000	-5,596,000	1,035,000	4,713,000	-1,925,000	5,528,000	-5,466,000	-2,946,000	-1,507,000	2,335,000	4,073,000	-97,000	-2,285,000	-394,000	-142,000	3,177,000	748,000	59,000	408,000	887,000
net decrease increase in cash and cash equivalents
cash and cash equivalents at beginning of period	0	246,375,000	0	0	0	276,402,000	0	0	0	456,661,000	0	0	0	513,448,000	0	0	0	470,166,000	0	0	0	198,911,000	0	0	0	138,838,000	0	0	0	174,935,000		0	0	102,055,000		0	0	48,132,000		-260,000	0	71,994,000		0	0	120,614,000		0	0	96,938,000		0	0	100,808,000	0	0	0	128,763,000	0	0	0	71,891,000	0	0	0	183,546,000	0	0	0	57,339,000	0	0	0	22,697,000	14,086,000
cash and cash equivalents at end of period	-21,190,000	239,104,000	31,218,000	-79,000	-376,670,000	591,906,000	2,670,000	-35,460,000	1,825,000	307,367,000	-55,276,000	64,785,000	40,060,000	407,092,000	43,217,000	72,817,000	-11,562,000	408,976,000	73,887,000	35,298,000	3,269,000	357,712,000	-9,070,000	31,897,000	19,059,000	157,025,000	-67,153,000	22,220,000	-5,625,000	189,396,000		327,343,000	30,487,000	124,113,000		20,795,000	9,717,000	77,086,000		-51,985,000	51,425,000	79,871,000		3,071,000	8,122,000	129,038,000		20,232,000	8,945,000	89,691,000		50,248,000	16,828,000	58,642,000	-10,183,000	-26,288,000	32,925,000	104,354,000	45,931,000	-10,786,000	11,944,000	81,674,000	-34,856,000	-31,970,000	-46,913,000	185,630,000	74,207,000	32,001,000	-121,675,000	199,013,000	-72,159,000	8,660,000	91,509,000	29,329,000	15,392,000
net increase in cash and cash equivalents		-7,271,000				315,504,000									43,217,000	72,817,000	-11,562,000	-61,190,000	73,887,000	35,298,000	3,269,000	158,801,000	-9,070,000	31,897,000	19,059,000	18,187,000	-67,153,000	22,220,000	-5,625,000	14,461,000	-307,008,000	327,343,000	30,487,000	22,058,000	-5,543,000	20,795,000	9,717,000	28,954,000																												2,084,000				141,674,000				6,632,000	1,306,000
lease incentive
gain on disposal of property and equipment and construction in-progress
gain from the sale of businesses											0
purchases of intangible assets
proceeds from sale of business
acquired in-process research and development and intangibles
proceeds from sales of property and equipment
proceeds from maturities of short-term investments
net proceeds on swaps designated as net investment hedges
purchase of treasury stock
net decrease in cash and cash equivalents			31,218,000					-35,460,000	1,825,000	-149,294,000		64,785,000	40,060,000	-106,356,000																																								-42,166,000
gain on disposal of property and equipment				72,000	1,253,000	12,000		100,000	-81,000	-23,000																												61,000				-19,000
cash (paid) for business acquisitions, net of cash acquired				0
proceeds from maturities of short term investments
net proceeds from swaps designated as net investment hedges												0
payments for contingent consideration				0
deferred income tax provision					-1,844,000	-2,856,000		1,237,000	-227,000	1,953,000		-6,103,000	3,998,000	3,544,000																															-2,066,000	1,563,000						-630,000	-1,571,000	-983,000																-1,852,000				-1,024,000
purchases of investments					-10,497,000	-38,500,000
net (decrease) in cash and cash equivalents
gain from the sale of business															169,000	230,000	679,000	-42,876,000
acquired in-process research and development milestone												0	0	-4,742,000						0
non-cash in-process research and development expense																							5,027,000
accretion of bond issuance discount																			4,340,000	4,295,000	4,251,000	2,529,000
net proceeds (payments) on swaps designated as net investment hedges
purchase of option hedge on convertible notes																			0	0	0	-104,248,000																																	0	0
proceeds from convertible notes issuance																			0	0	0	575,000,000
proceeds from sale of stock purchase warrants																			0	0	1,000	44,562,000																																																	0	0
proceeds from sale of property and equipment																				9,000	3,268,000	34,000		1,000	0	35,000		93,000	57,000	148,000		14,000
proceeds from sale of businesses
proceeds from sale of extremity orthopedics business															0	-1,268,000	0	191,736,000
loss on disposal of property and equipment and construction in-progress
proceeds from note receivable																							0	257,000	250,000	245,000	231,000	233,000	225,000	221,000
acquired in-process research and development																						-5,000,000	0
net cash (used) provided by financing activities																1,743,000	-97,475,000	-3,015,000
cash (paid) provided for business acquisitions, net of cash acquired																	-1,283,000	-302,627,000
income tax expense																			-68,922,000
cash from business acquisitions, net of cash acquired																																																											-1,007,000
net proceeds(payments) on swaps designated as net investment hedges
net cash paid for contingent consideration
proceeds from the issuance of common stock, net of issuance costs																											0	-9,000
deferred income tax benefit/provision																						5,068,000
amortization of debt issuance costs																							1,306,000	1,371,000	1,356,000	1,357,000	1,317,000	1,296,000	2,138,000	1,519,000		394,000	391,000	393,000		387,000	620,000	616,000		585,000	530,000	530,000		817,000	635,000	608,000		613,000	549,000	545,000		623,000	720,000	760,000	757,000	792,000			425,000
realized loss on sale of short-term investments
gain on divestiture of business
proceeds from sale of short-term investments																																0	6,975,000	9,976,000
proceeds from divestiture of business
debt issuance costs																																																							0	-59,000			0
deferred income tax																								-1,459,000	-2,234,000	-6,843,000		1,212,000	1,213,000	-1,636,000		203,000	-1,145,000	7,000		-2,277,000	-1,584,000	942,000		30,930,000	464,000	1,184,000																							-1,431,000	-419,000
change in fair value of contingent consideration and other																								0	-184,000	194,000		300,000	535,000	379,000		-778,000	-2,256,000	261,000
changes in assets and liabilities, net of business acquisitions:
net cash paid for financing liabilities from business acquisitions																												0
net cash (used in) / provided by financing activities
cash from business acquisitions																												0
deferred revenue																										-188,000	1,615,000	-20,000				-678,000	832,000	1,251,000		-1,129,000	983,000	1,527,000		620,000	-36,000	-769,000		881,000	167,000	21,000		708,000	-113,000	391,000		-624,000	245,000	-534,000	920,000	292,000	-480,000	-628,000	110,000	148,000	-259,000	-456,000	-309,000	364,000	-153,000	-191,000	-799,000	562,000	-891,000	756,000	-2,125,000	596,000	-609,000	-933,000	19,000
non-cash interest expense																																				2,132,000	2,104,000	2,064,000		2,130,000	1,885,000	1,859,000		1,823,000	1,767,000	1,666,000		1,633,000	1,622,000	1,610,000		1,788,000	2,968,000	3,528,000	3,472,000	3,487,000	1,998,000	1,634,000	1,606,000	1,578,000	1,888,000	2,053,000	2,038,000	2,334,000	2,765,000	2,762,000
payment of accreted interest																																																				0							0	0			-1,396,000	-1,273,000	-1,178,000	-1,544,000
change in restricted cash																																				0	0	4,165,000
payment of liability component of convertible notes
payment of capital lease obligation
realized loss on sale of short-term investment																																0
borrowings under senior credit facility																												0	25,000,000	25,000,000		326,383,000	35,000,000	210,000,000		0	0	15,000,000		510,000,000				150,000,000	0	235,000,000		10,000,000				0			10,000,000	50,000,000			30,000,000	0							60,000,000	80,000,000	0	120,000,000	0	0	36,000,000	39,000,000
repayments under senior credit facility																												-45,000,000	-380,000,000	-35,000,000		-35,000,000	-10,000,000	-20,000,000		-20,000,000	-26,875,000	-1,875,000		-433,750,000	0	-15,000,000										0	1,000	-12,813,000	-22,812,000	-1,875,000	-146,875,000	-41,875,000	-1,875,000	0	0	-15,000,000	0	-40,000,000
cash from business acquisition																														5,720,000																						690,000	-2,692,000	-175,000
net cash paid for financing liability from business acquisition																														-7,772,000
net cash provided (used in) by financing activities
effect of exchange rate fluctuations on cash
cash from business acquisition, net of cash acquired																																192,000	-31,816,000	-193,928,000										0	0	-235,000,000		-150,000	-64,000	-2,766,000						-68,621,000								-645,000	-138,000	-4,003,000		-77,811,000	-27,000	-6,000		-368,000	-33,731,000	-2,324,000
cash received from business acquisition purchase price adjustment																																				1,000
principal payments under capital lease obligations																																				-164,000	-163,000	-160,000		-157,000	-218,000	-178,000		-125,000	-123,000	-122,000
net cash received for contingent consideration
income from discontinued operations, net of tax
change in fair value of contingent consideration																																				-170,000	120,000	131,000		120,000	114,000	125,000
net cash from operating activities of continuing operations																																				46,767,000	43,938,000	19,171,000
net cash from operating activities of discontinued operations
sale of property and equipment																																								0	0	1,438,000
net cash from investing activities of continuing operations																																				-6,707,000	-8,043,000	-6,730,000
net cash from investing activities of discontinued operations
repayment of 2016 convertible notes
distribution to seaspine
excess tax benefits from stock-based compensation arrangements																																						-1,808,000		-177,000	-2,380,000	-1,121,000		-43,000	-623,000	-541,000		-38,000	-79,000	-23,000		-14,000	-415,000	-3,000	-4,000	-66,000	-725,000	-53,000	-105,000	-1,000	-562,000	-2,912,000	-6,000	-7,000	1,000	-8,000	-228,000	-703,000	-593,000	-66,000	-430,000	-405,000	-135,000	-254,000
loss (income) from discontinued operations, net of tax
proceeds from working capital purchase price adjustment																																									0	1,831,000
net change in cash and cash equivalents																																									51,425,000	7,877,000		3,071,000	8,122,000	8,424,000		20,232,000	8,945,000	-7,247,000		50,248,000				-26,288,000	32,925,000	-24,409,000		-10,786,000	11,944,000	9,783,000		-31,970,000				32,001,000				8,660,000
(gain) from change in fair value of contingent consideration																																												120,000
sales of property and equipment																																																3,000	-2,000	532,000
purchases of short-term investments																																																				0	-14,659,000	-53,248,000
maturities of short-term investments
other																																																						277,000													0	0	0	18,000	238,000	325,000			-11,000
proceeds from liability component of convertible notes																																																							0
proceeds from equity component of convertible notes																																																							0
sales of short-term investments
proceeds from liability component of convertible notes issuance
proceeds from equity component of convertible notes issuance
repurchase of liability component of convertible notes																																																											0	0			-17,128,000	-16,058,000	-16,831,000	-27,988,000
proceeds from exercise of stock options																																																						250,000				1,687,000				2,624,000
in-process research and development																																																															0				0
gain on convertible note repurchases
other liabilities
proceeds from the sale of stock purchase warrants																																																							0
amortization of bond issuance costs																																																										517,000			317,000	357,000	447,000	519,000	610,000	824,000	605,000	608,000	608,000	610,000	590,000	585,000	146,000	91,000
refundable income taxes
gain on bond repurchases																																																																207,000
purchase of intangible assets
gain on sale of assets/investments
income taxes payable																																																																						4,755,000	11,068,000	-8,955,000	-2,750,000	1,872,000
proceeds from issuance of convertible notes																																																																							0	0
purchase option hedge on convertible notes																																																																							0	0
convertible note issuance and other financing costs																																																																							-2,000
proceeds from exercised stock options and warrants																																																																											1,434,000
cash paid during the year for interest
cash paid during the year for income taxes
supplemental non-cash disclosure:
acquisition fees included in liabilities
property and equipment purchases included in liabilities
repayment of loans																																																																						-178,000				-39,014,000
gain on bond repurchase																																																																		-1,213,000
net cash (used in) investing activities																																																																		-7,049,000				-2,850,000				-6,173,000
(gain) loss on sale of assets/investments																																																																							52,000
amortization of discount/premium on investments
proceeds from the sales of investments
purchases of available for sale investments
cash from acquisitions, net of cash acquired
repayment of convertible notes and credit facility
gain on sale of assets
proceeds from sale of assets																																																																								32,000
repayment of loans and credit facility																																																																				0			77,000	-69,000
convertible note issuance costs
derivative loss
accounts payable
other accrued expenses and current liabilities
deferred tax liabilities
proceeds from sales/maturities of investments
purchases of available-for-sale investments																																																																											-2,891,000
(gain) loss on sale of assets
impairment of fixed assets
derivative gain																																																																										168,000
accounts payable accrued expenses and other liabilities																																																																										-6,559,000
proceeds from sales/maturities of available-for-sale investments
loss on sale of assets/investments
accounts payable, accrued expenses and other liabilities																																																																											342,000
net cash (used in)/provided by investing activities
fees paid in connection with bank line of credit
repayment of bank loans
gain on sale of product line and investments
non-current assets																																																																											301,000
customer advances and deposits																																																																											2,390,000
proceeds from sale of product line and other assets
proceeds from sale/maturity of investments
net proceeds from revolving credit facility																																																																											770,000
repayment of term loan																																																																											-625,000
repayment of note payable																																																																											-1,540,000
proceeds from sale of preferred stock
preferred dividends paid
effect of exchange rate changes on cash																																																																											4,000
non-cash investing activities:
note issued in a business acquisition

We provide you with 20 years of cash flow statements for Integra LifeSciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Integra LifeSciences stock. Explore the full financial landscape of Integra LifeSciences stock with our expertly curated income statements.

The information provided in this report about Integra LifeSciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.